Description
SCULLPTRA FACIAL IMPLANT
First action · last action
2017-04-20 · 2018-01-26
Transactions
2
First transaction's obligation
$4,515
Base + all options value (sum of deltas)
$0
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
339113 · SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-04-20+$4,515= $4,515
- Mod P000012018-01-26-$4,515= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-04-20 | +$4,515 | $4,515 | SCULLPTRA FACIAL IMPLANT |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-01-26 | −$4,515 | $0 | SCULLPTRA FACIAL IMPLANT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MNX4XY6QXEL3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0834 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $16,960 | FY2026 |
| 36C26226N0818 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $50,880 | FY2026 |
| 36C24526N0594 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,800 | FY2026 |
| 36C24526N0514 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $42,400 | FY2026 |
| 36C24526N0423 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,800 | FY2026 |
| 36C24526N0298 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,800 | FY2026 |
Other recipients under 6515 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626P1036 | LUMIBIRD MEDICAL INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $17,425 | FY2026 |
| 36C24626P1048 | AMAJS GROUP, INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $19,462 | FY2026 |
| 36C24626N1013 | PERMOBIL INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $52,460 | FY2026 |
| 36C24626N1022 | CARDINAL HEALTH 200, LLC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $617,758 | FY2026 |
| 36C24626P1056 | TOP END SPORTS LLC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $20,875 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24617P4949_3600_-NONE-_-NONE- · retrieved 2026-09-26.